496
Views
67
CrossRef citations to date
0
Altmetric
Rapid Communication

Methoxetamine associated reversible cerebellar toxicity: Three cases with analytical confirmation

, , , , &
Pages 438-440 | Received 29 Feb 2012, Accepted 03 Apr 2012, Published online: 11 May 2012

References

  • Hofer KE, Grager B, Muller DM, Rauber-Luthy C, Kupferschmidt H, Rentsch KM, . Ketamine-like effects after recreational use of methoxetamine. Ann Emerg Med [Epub] 2012 Jan 9.
  • Gibbons S. Legal highs: novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol 2012; 50:15–24.
  • Wood DM, Davies S, Puchnarewicz M, Johnston A, Dargan PI. Acute toxicity associated with the recreational use of the ketamine derivative methoxetamine. Eur J Clin Phamacol [Epub] 2011 Dec 29.
  • Mak SK, Chan MT, Bower WF, Yip SK, Hou SS, Wu BB, Man CY. Lower urinary tract changes in young adults using ketamine. J Urol 2011; 186:610–614.
  • Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow…and back again. A review of herbal marijuana alternatives (K2, spice), synthetic cathinones (bath salts), kratom, salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012; 8:15–32.
  • Ward J, Rhyee S, Plansky J, Boyer E. Methoxetamine: a novel ketamine analog and growing health-care concern. Clin Toxicol 2011; 49:874–875.
  • Waring WS, McGettigan P. Clinical toxicology and drug regulation: a United Kingdom perspective. Clin Toxicol 2011; 49:452–456.
  • Mark M. Emerging drugs of abuse: what was new yesterday is new today. J Med Toxicol. 2012;8:1–2.
  • Erowid: methoxetamine website http://www.erowid.org/chemicals/methoxetamine/methoxetamine.shtml [accessed 01/03/2012].
  • Kalsi SS, Wood DM, Dargan PI. The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threat J 2011; 4:7107.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.